Papers

1

Total Citations

26

H-Index

1

About

Dr. Yiqi Yu is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for complex pancreatic surgeries. Her most impactful work includes a landmark 2022 meta-analysis comparing robotic versus open pancreaticoduodenectomy, which has garnered 26 citations and provided critical evidence that robotic approaches can achieve comparable oncologic outcomes—including R0 resection rates and lymph node harvest—while reducing blood loss and complication rates. This study has become a foundational reference for surgeons evaluating the adoption of robotic platforms in pancreatic cancer care. Beyond this meta-analysis, Dr. Yu's broader research portfolio systematically evaluates perioperative outcomes in hepatopancreatobiliary surgery, with a particular focus on optimizing surgical techniques to improve patient recovery without compromising cancer clearance. Her work bridges the gap between traditional open surgery and emerging robotic technologies, offering data-driven guidance for clinical decision-making. By synthesizing evidence from cohort studies worldwide, Dr. Yu has helped establish benchmarks for operative time, blood loss, and complication rates that inform both surgical training and institutional protocols. Her contributions are shaping the future of pancreatic surgery, making complex procedures safer and more accessible for patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Meta-analysis of robotic versus open pancreaticoduodenectomy in all patients and pancreatic cancer patients
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago